‘Magic mushrooms’ can provide effective treatment for depression after one or two doses, a new study has found. A single dose of Psilcybin, which is the active ingredient in magic mushrooms, has been ...
A single dose of psilocybin coupled with “talk therapy” can significantly reduce depression in people with cancer for up to two years, according to a new study. While the study has limitations, its ...
A study of mice fed a high-fat/high-fructose diet (designed to induce obesity) found that 12 weeks of treatment with low-dose psilocybin reduced weight gain, symptoms of fatty liver, hyperglycemia, ...
A single dose of psilocybin, a compound found in "magic mushrooms" provides long-term relief from anxiety and depression in cancer patients, a new study finds.In fact, cancer patients who were given ...
A single dose of psilocybin combined with psychological support can provide lasting relief from depression and anxiety in patients with cancer. In a phase 2 clinical trial, more than half of patients ...
New results from a clinical trial reveal that a single dose of psilocybin-a naturally occurring psychedelic compound found in mushrooms-can provide sustained reductions in depression and anxiety in ...
The U.S. Food and Drug Administration issued its first formal guidance on how to design and run clinical trials for psychedelic drugs, a move that directly clears a path for psilocybin, the active ...
Updated Part B results demonstrated sustained efficacy for COMP360 psilocybin 25mg, maintaining symptom severity reductions through week 26 after just 1 or 2 doses.
Please provide your email address to receive an email when new articles are posted on . Patients treated with high-dose psilocybin had better responses compared with placebo in antidepressant trials.
A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer ...
In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.